DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma ITMTX Vs IVMTX For CNS Relapse In High-Risk DLBCL Sep 27, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) T-DXd Shows Durable Response And Manageable Safety In Patients With HER2m mNSCLC Sep 26, 2023
DLBCL (Diffuse Large B Cell Lymphoma),FL (Follicular Lymphoma),Lymphoma Epcoritamab + R2 Regimen Improves Outcomes In Patients With High‑Risk Follicular Lymphoma Sep 26, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) OSI With LCT Is Safe For Metastatic EGFR Mutant NSCLC Sep 26, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Cemiplimab + Chemo Shows Better Outcomes Than Chemoy Alone In NSCLC Sep 26, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Perioperative Cabozantinib And Nivolumab Is Safe To Administer In mccRCC Patients Sep 26, 2023
Bladder Cancer,Genitourinary Cancer Familiarity With PDD Or Blue Light Cystoscopy May Improve WL Resection Sep 26, 2023
